News
New Regulations Allow Medicare to Negotiate Drug Prices
Medicare can now negotiate drug prices, with the first 10 medications subject to price negotiations. Learn about the potential impact on pharmaceutical companie...
Apellis Pharmaceuticals Announces Workforce Restructuring to Drive Growth
Apellis Pharmaceuticals announces a strategic restructuring initiative to enhance growth, reduce expenses, and prioritize Syfovre and Empaveli products. The com...
Zip Co. Cuts Annual Loss and Expects Positive Earnings
Zip Co. announces a reduction in its annual loss and expresses confidence in achieving positive earnings in the first half of the fiscal year. Revenue increased...
Ross Acquisition Corp. II Receives Compliance Notice from NYSE
Blank check company Ross Acquisition Corp. II has received a compliance notice from the New York Stock Exchange (NYSE) for failure to file its quarterly report.
Shifting Dynamics in the Republican Presidential Primary
The Republican primary sees shifting dynamics as Trump's support declines slightly and other contenders gain momentum. Explore the key moments from the recent d...
The Diverging Fortunes of the Stock Market
This article examines the underperformance of smaller market value stocks in the recent stock market rally and its impact on overall market sentiment.
Chinese Stocks Surge with Government Measures
Chinese stocks surge as government implements measures to boost capital markets, including reductions in stamp duty and new listing restrictions. Positive marke...
Stocks in the Asia-Pacific Region Rise
Stock markets in the Asia-Pacific region mostly experienced gains on Monday, Aug. 28, with notable changes in Nikkei 225 and Hang Seng Index constituents.
Investors Demand Higher Premiums for Long-Term Bonds
Investors are demanding greater compensation for the risks associated with long-term bonds as term premiums on the 10-year U.S. Treasury note reach their highes...
Berkshire Hathaway Inc. Cl B Shares Inch Higher
Berkshire Hathaway Inc. Cl B shares rose 0.46% on Friday, closing at $355.93. The company experienced consistent growth but fell short of its 52-week high. It u...